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TO THE EDITOR
Cylindromas are usually benign skin
appendage tumors that are most fre-
quently found in scalp and neck skin,
with a strong predilection for middle-
aged and elderly females (Weedon,
2002). Cylindromas are characterized
by irregularly shaped islands of basa-
loid cells arranged in a ‘‘jigsaw puzzle’’
pattern, which are surrounded by an
eosinophilic hyaline sheath (Figure 1a,
arrowheads). They exhibit multiple
molecular defects in their basement
membrane zone, including the lack of
mature hemidesmosomes, defective
processing of laminin 5 (Tunggal
et al., 2002), and abnormalities in
collagen IV alpha 1- and alpha 5-chain
expression (Quatresooz and Pierard,
2005). In the tumor islands, a peripheral
palisade of relatively undifferentiated
cells with small, dark nuclei (Figure 1b,
arrows) can be distinguished from
more differentiated cells with large,
pale nuclei, which resemble ductal or
secretory cells (Requena et al., 1998;
Weedon, 2002; Klein et al., 2005;
Figure 1b, **).
Conventional wisdom classifies cy-
lindroma as a neoplasm of apocrine
differentiation (Weedon, 2002; Klein
et al., 2005), even though circumstan-
tial ultrastructural and immunohisto-
chemical evidence has also been
presented in favor of an eccrine origin
of cylindroma (Crain and Helwig 1961;
Cotton and Braye, 1984; Penneys and
Kaiser, 1993; Ishihara et al., 1998).
However, the fact that cylindromas
exclusively arise in hair follicle-bearing
regions of the integument, but not in
palmoplantar skin – which is rich in
eccrine glands, yet devoid of pilosebac-
eous units and apocrine glands –
already argues against an eccrine ori-
gin. Despite the exploitation of a wide
range of enzymehistochemical, immuno-
histological, and ultrastructural mar-
kers, none of these has as yet been
generally accepted as definitive proof
for one or the other concept, and
the histogenesis of cylindromas has
remained a subject of intense and
controversial debate (for discussion,
see Requena et al., 1998; Weedon,
2002; Klein et al., 2005).
This debate is important as it directly
relates to the question of whether
cylindromas arise from pluripotent hair
follicle epithelial stem cells (as specu-
lated, e.g., by Schirren et al. (1995) and
Requena et al. (1998)) that can differ-
entiate into the follicular, apocrine, or
sebaceous lineage, but do not generate
eccrine sweat glands, or whether they
arise from a distinct epithelial precursor
population that would give rise only to
eccrine glands, but to none of the
differentiation pathways recognized
for the progeny of hair follicle epithelial
stem cells (Fuchs et al., 2004).
During fetal hair follicle morphogen-
esis, in human skin, the apocrine gland
arises from the keratinocytes of the
developing outer root sheath. These,
in turn, arise from epithelial stem cells
located in the bulge region of the outer
root sheath. The same is true of the
sebaceous gland (Philpott and Paus,
1998; Requena et al., 1998). Therefore,
the concept of an apocrine histogen-
esis, and even the sebaceous-type
differentiation pattern that one can
sometimes find in a cylindroma (Requena
et al., 1998), are fully compatible with
that of a hair follicle origin of cylindroma:
follicular, sebaceous, and apocrine
differentiation pathways all arise from
the same precursor cells in the hair
follicle outer root sheath, likely from
bulge epithelial stem cells or their
immediate progeny.
Even the previously postulated ec-
crine origin of cylindroma (Crain and
Helwig 1961; Cotton and Braye, 1984;
Penneys and Kaiser, 1993; Ishihara
et al., 1998) would not be entirely
irreconcilable with a follicular histo-
genesis of cylindroma, if one considers
the recognized pluripotentiality of hair
follicle epithelial stem cells: these
can regenerate a complete epidermis
(Taylor et al., 2000; Fuchs et al., 2004;
Morris et al., 2004; Wu et al., 2004),
from where eccrine glands originate
(Hashimoto et al., 1966).
As none of the previously examined
markers has been universally accepted
as definitive proof for either an apoc-
rine or eccrine origin of cylindroma
(Weedon, 2002, Klein et al., 2005),
we argued that the question of whether
or not cylindroma originates from
epithelial cells committed to the folli-
cular–apocrine–sebaceous or to the
eccrine differentiation pathway should
be settled, if one can demonstrate the
expression of markers of advanced hair
follicle-type differentiation that are spe-
cific to the hair follicle and that
are definitely not expressed in eccrine
glands.
Therefore, we immunostained cylin-
droma cryosections obtained during
routine surgery from ‘‘turban tumors’’
of three female (60, 65, and 69 years
old) patients with Brooke–Spiegler syn-
drome with informed consent (the
medical ethical committee of the Max-
Planck-Institute for Biochemistry ap-
proved all the studies described and
the study was conducted according to
the Declaration of Helsinki Principles),
with specific antisera against human
keratin 17 (K17), human hair keratin
hHb2 (Langbein et al., 2001), human
K6hf (Winter et al., 1998), or human
K6irs1 (Langbein et al., 2002). Although
K17 expression is not entirely specific
to human hair follicles, in normal
human skin, it is most prominently
expressed in the hair follicle outer root
sheath, and is absent from eccrine
glands and their ducts. Human hair
keratin hHb2 is selectively expressed in
the hair cuticle, K6Hf in the companion
layer, and K6irs1 in the Huxley, Henle
layers, and the cuticle of the inner root
sheath (Winter et al., 1998; Langbein
et al., 2001, 2002).
Horizontal sections of scalp hair
follicles immediately adjacent to theAbbreviation: K17, keratin 17
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cylindroma mass were employed as
internal positive control and showed
the expected immunoreactivity patterns
(Figure 1c–e, insets). The tumors were
diagnosed as a typical benign cylin-
droma by pattern analysis of the classi-
cal diagnostic criteria established for
this tumor (Figure 1a and b; Requena
et al., 1998).
As shown in Figure 1, cylindroma
sections displayed prominent cytoplas-
matic immunoreactivity of the tumor
epithelium for K17, K6irs1, K6Hf
(Figure 1c–e), and hHb2 (not shown).
The observed expression of K17 in
cylindromas (which has previously
been noted in trichoepithelioma, but
not cylindroma; Schirren et al., 1995) is
also consistent with a hair follicle-
type differentiation of this tumor.
The expression of hair-specific keratins
suggests that the examined tumors
could not possibly be of eccrine
origin. Even though this remains to be
verified by the analysis of additional
cylindroma specimen from different
individuals, given the very typical
morphology of the examined cylindro-
ma (Figure 1a and b), our data imply
that this tumor generally is of hair
follicle origin.
For K17, K6irs1, and K6Hf, a differ-
ential expression pattern was noted:
a weaker basal layer immunoreac-
tivity (corresponding to the peripheral,
palisading layer of less differentiated
tumor epithelium; Figure 1c–e, **)
contrasted with a stronger immunor-
eactivity in the more differentiated
layers of the tumor epithelium (Figure
1c–e, arrowheads). This is consistent
with the concept that the neoplastic
transformation giving rise to cylindroma
development occurs in transit amplify-
ing cells derived from a precursor cell
pool of outer root sheath keratinocytes
that are already committed to the hair
follicle-type differentiation pathway,
but are still capable of differentiating
into various, distinct phenotypes within
the follicular–apocrine–sebaceous spec-
trum of epithelial differentiation. As
hair follicle epithelial stem cells can
also enter into the epidermal pathway
of epithelial differentiation (Taylor
et al., 2000; Fuchs et al., 2004; Wu
et al., 2004), from where, in theory,
even an eccrine-gland-type differentia-
tion pattern could then develop, even
‘‘eccrine’’ features of a cylindroma are
not necessarily incompatible with a
primary follicular origin of this neoplasm.
A truly convincing, specific marker
for human epithelial hair follicle stem
cells is still not available (with even
the specificity of K15 expression as
such a marker still being disputed;
cf. Li et al. (1998), Porter et al. (2000),
and Morris et al. (2004)), and label-
retaining experiments can evidently
not be performed in cylindroma
patients. Therefore, the presence and
location of epithelial hair follicle
stem cells and/or their (still highly
undifferentiated, yet already partially
committed) progeny within the
cylindroma epithelium remain to be
demonstrated.
The examined patients suffered from
familial cylindromatosis (Brooke–Spieg-
ler syndrome; OMIM numbers 123850,
132700, 313100, and 605041). The
gene for familial cylindromatosis was
mapped to chromosome 16q12–q13 by
linkage analysis (Biggs et al., 1995).
Subsequently, the CYLD gene was
discovered by positional cloning, and
mutations in CYLD –a tumor suppressor
gene – were identified in families
with this disease (Bignell et al., 2000;
Poblete-Gutierrez et al., 2002). These
mutations predict truncation or absence
of the encoded protein (Bignell et al.,
2000). In affected patients, cylindromas
may arise through constitutive NF-kB
activation (e.g. owing to the inability of
mutated CYLD to downregulate this
activation; Brummelkamp et al., 2003;
Regamey et al., 2003).
Therefore, we also employed a
specific rabbit antiserum we have most
recently raised against a consensus
sequence of mouse and human CYLD
(Massoumi R, Chmielarska K, Hen-
necke K, Pfeifer A, Fa¨ssler R (2006)
Cyld inhibits tumor cell proliferation by
blocking Bcl-3-dependent NF-kB signa-
ling). Figure 1g and h shows the first
evidence that CYLD protein is promi-
nently expressed in the inner root
sheath of normal human scalp hair




































Figure 1. Expression of human hair follicle keratins and CYLD in cylindroma. Periodic acid Schiff (PAS)
stain (LM) of cylindroma derived from female patient with familial cylindromatosis (Brooke–Spiegler
syndrome) and multiple ‘‘turban tumors’’ (a and b; bars 100, respective 25mm). Undifferentiated cells
with small, dark nuclei (b, arrows) can be distinguished from more differentiated cells with large, pale
nuclei (b, **). For immunohistochemistry and immunofluorescence, skin samples or cylindroma sections
were frozen in 22-oxacalcitriol (OCT; Thermo Shandon) and cryosections of 10 mm thickness were cut
and fixed with methanol/acetone. After blocking in 3% BSA/phosphate-buffered saline, the sections were
stained with the primary antibodies directed against K17 (1:4000; c), K6irs1 (1:1:500; d), K6Hf (1:2000;
e), and CYLD (1:500; f–h). The basement membrane was demarcated with a6-integrin antibodies (c–f).
After washing, the sections were stained with specific secondary antibodies and DAPI (40,6-diamidine-20-
phenylindole dihydrochloride) (g) before mounting and analyzing with Leica confocal microscope. The
arrows in (c)–(e) represent less differentiated tumor epithelium, whereas the asterisks represent more
differentiated layers of the tumor epithelium (bars¼ 25 mm). The insets in (c)–(f) shows expression of scalp
hair follicle keratins immediately adjacent to the cylindroma mass. CYLD expression pattern (Huxley
layer; HU) in normal human scalp hair follicles (g) and arrowheads in (h) represent expression pattern of
CYLD in Huxley cells (‘‘Flu¨gelzellen’’) (bars¼ 25 mm).
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in ‘‘Flu¨gelzellen’’ (Figure 1h, arrow
heads).
We also demonstrate here that CYLD
immunoreactivity is dramatically
downregulated in the epithelium of
familial cylindromas (Figure 1f), com-
pared to its strong immunoreactivity in
a defined compartment of the hair
follicle epithelium of the same patient
(Figure 1f, inset). Even though this
downregulation of CYLD immunoreac-
tivity would seem to be consistent with
a role for defective or insufficiently
produced CYLD protein in cylindroma
development, the current study does
yet allow to draw any conclusions on
the functional role of CYLD in the
pathogenesis of familial cylindroma.
However, the fact that this tumor
suppressor gene product, which shows
its expression maximum in human hair
follicle inner root sheath keratinocytes
(Figure 1f (inset), g, and f), is expressed
at all in a cylindroma further supports
the concept that this skin appendage
tumor is of follicular origin.
In summary, our data suggest that
cylindroma epithelium likely originates
from epithelial hair follicle, whose exact
differentiation pathway (follicular versus
apocrine versus sebaceous, and may be
even eccrine) may be dictated by the
nature of the epithelial–mesenchymal
signaling in a given patient and skin
location as in every normal hair follicle.
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